>
They Couldn't Afford Compost… So Woodchips Saved This Garden
Stop Poisoning Your Soil: It's Worse Than You Think!
The Economist Who Called 2008 Says The Debt Crisis Warning Is A Myth -- We Had To React
The 'Projects' That Could Ignite The Next World War
Anthropic is launching its own drug discovery programs for rare diseases using Claude...
SpaceX AI Satellites Will Have 250 Kilowatts of Power
Chinese researchers have developed a sodium-metal battery that can fully charge in just 4 minutes...
SpaceX Starship Flight 13 in 3 Days - Thursday July 13
Chinese Scientists Develop Nuclear Battery Using Carbon-14
Teleoperated humanoid robots complete first-ever live surgery
Floating capsule auto-disinfects water without chemicals or battery
Modular Reactors To Solve Data Center Hysteria?
DeepSeek Developing In-House AI Chip In Bid To Cut Nvidia Reliance
America just took three brand-new nuclear reactors critical in thirty days, a first for any...

Now, researchers have developed a tiny, rotini-shaped spiral that could one day be deployed in the thousands for targeted drug delivery.
Current treatments for eye diseases such as glaucoma or diabetic macular edema are delivered through direct injection or eyedrops. Those methods are effective but imprecise, often blanketing the entire eye in medication.
So scientists used nanoscale 3D printing to create spiral-shaped robots small enough to pass through the dense jelly known as the vitreous humor that makes up most of the eyeball. The researchers added a slippery coating and magnetic materials so they could propel the microbots through the eye using a magnetic field.
The scientists then collected pig eyes from a slaughterhouse, injected a solution containing about 10,000 bots into each eye, and then placed them in a magnetic field, which they used to propel the bots to the retina at the back of the eye. Imaging showed the swarm successfully reached the retina in less than 30 minutes, about 10 times faster than letting similar-size particles diffuse through the eye, the researchers reported last week in Science Advances.